Cysteine

Cysteine

SCHEMBL8501902

N[C@@H](CS)C(=O)[O-].N[C@@H](CS)C(=O)[O-].[Na+].[Na+]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 1/20 0.55
CA4 known ✓ P22748 2/20 0.35
SLC7A11 Q9UPY5 1/20 0.55
ENPEP Q07075 11/20 0.37
ANPEP P15144 2/20 0.36
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.32
LDHA P00338 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL6570272 1.00
Cysteine SCHEMBL28776326 1.00
Cysteine SCHEMBL3425155 1.00
Cysteine SCHEMBL30808400 0.97
Cysteine SCHEMBL5063585 0.97
Cysteine SCHEMBL5063587 0.97
Cysteine SCHEMBL10935445 0.97 PTGS1 (0.52) PTGS1SLC7A11ENPEPANPEPCA4
Cysteine SCHEMBL23903319 0.94 PTGS1 (0.55) PTGS1SLC7A11ENPEPANPEPCA4
Cysteine SCHEMBL5046068 0.94
Cysteine SCHEMBL16194528 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236878-A1 COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS SPOGEN BIOTECH INC. 2025-07-24 US disclosed
CN-113943694-A Universal serum-free medium supporting adherence or suspension culture of various vaccine cells and preparation method thereof 无锡多宁生物科技有限公司 2022-01-18 CN disclosed
EP-3914068-A1 COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS Spogen Biotech Inc. (US) 2021-12-01 EP disclosed
CN-113395898-A Compositions for treating citrus disease and promoting yield enhancement of row crops 斯波根生物技术公司 2021-09-14 CN disclosed
US-20200255851-A1 COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS GENISYS CREDIT UNION 2020-08-13 US disclosed
WO-2020154387-A1 COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS SPOGEN BIOTECH INC. (US) 2020-07-30 WO disclosed
US-5981197-A DETECTING OR MEASURING BASIC FIBROBLAST GROWTH FACTOR USING IMMUNOGLOBULIN; ACTIVATING CELL PROPAGATION; THERAPY FOR THROMBOSIS AND ARTERIOSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-11-09 US disclosed
EP-0288687-B1 Monoclonal antibody, hybridoma, their production and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1994-12-28 EP disclosed
EP-0288687-A2 Monoclonal antibody, hybridoma, their production and use thereof Takeda Chemical Industries, Ltd. (JP) 1988-11-02 EP disclosed